Investment Update: Driehaus Capital Management LLC Q3 2022 vs. Q4 2022

Driehaus Capital Management LLC has released its Q3 2022 vs. Q4 2022 13F Holdings Comparison report. The report details the changes in holdings of funds managed by the firm. In this article, we'll delve deeper into some of the changes that have occurred in the firm's holdings.

First, let's take a look at some of the companies that have seen significant changes in holdings. Xenon Pharmaceuticals Inc. (XENE) saw Driehaus Capital Management LLC's holdings increase from 4,504,020 shares to 4,681,797 shares, which represents a change of 13.5%. Kinssale Capital Group Inc. (KNSL) also saw an increase in holdings, from 306,997 shares to 319,221 shares, which represents a change of 6.5%. And ELF Beauty Inc. (ELF) saw a significant increase in holdings, from 1,080,617 shares to 1,321,665 shares, which represents a change of 79.8%.

On the other hand, some companies saw a decrease in Driehaus Capital Management LLC's holdings. Crinetics Pharmaceuticals Inc. (CRNX) saw a decrease from 5,631,958 shares to 5,624,744 shares, which represents a change of -6.9%. And Celsius Holdings Inc. (CELH) saw a decrease from 801,288 shares to 523,981 shares, which represents a change of -25%.

Looking at the overall holdings, Driehaus Capital Management LLC's total holdings decreased by -0.58%, from $6,199,715 in Q3 2022 to $6,162,168 in Q4 2022. This change can be attributed to a combination of new investments and divestments. It's important to note that these changes in holdings do not necessarily reflect the performance of the companies.

In conclusion, Driehaus Capital Management LLC's Q3 2022 vs. Q4 2022 13F Holdings Comparison report shows a mix of increases and decreases in holdings. It's clear that the firm is making moves to adjust its portfolio, but it's also clear that the overall holdings remain quite stable. Investors should keep an eye on these changes and stay informed about the companies in which they're invested.